Please enable JavaScript in your browser to complete this form.
Thank you for participating in the 3rd SEA NSCLC ACADEMY. Please answer the following questions.
Name:
I understand the importance of KRAS G12C screening
*
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Strongly Agree
Item #1 Strongly Agree
Agree
Item #1 Agree
Neutral
Item #1 Neutral
Disagree
Item #1 Disagree
Strongly Disagree
Item #1 Strongly Disagree
I am confidence in prescribing KRAS G12C inhibitor(s) in suitable patients once it is approved in the market
*
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Strongly Agree
Item #1 Strongly Agree
Agree
Item #1 Agree
Neutral
Item #1 Neutral
Disagree
Item #1 Disagree
Strongly Disagree
Item #1 Strongly Disagree
I am confidence in managing the adverse event emergent after prescribing KRAS G12C inhibitor(s)
*
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Strongly Agree
Item #1 Strongly Agree
Agree
Item #1 Agree
Neutral
Item #1 Neutral
Disagree
Item #1 Disagree
Strongly Disagree
Item #1 Strongly Disagree
Submit
